Test Price
2,800 AED✅ Home Collection Available
ATP2B3 Gene Spinocerebellar Ataxia Type 1 (X‑Linked) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accurate diagnostic sequencing of the ATP2B3 gene for X‑linked spinocerebellar ataxia type 1, performed at DNA Labs UAE under DHA License 1143.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited NGS processing with full gene coverage and CNV analysis.
- Premium Logistics: Paid hospital‑grade VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post‑test clinical guidance and genetic counseling by board‑certified specialists.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced NGS test sequences the entire ATP2B3 gene to detect pathogenic mutations causing X‑linked spinocerebellar ataxia type 1. It provides a definitive molecular diagnosis for at‑risk individuals, differentiates the condition from other hereditary ataxias, and informs family planning and carrier testing. The methodology combines next‑generation sequencing with Sanger confirmation for 99.9% sensitivity and detection of deep intronic variants.
| Feature | Our ISO‑Certified ATP2B3 NGS Test | Standard Hospital Panel (Alternative) |
|---|---|---|
| Precision | 99.9% sensitivity; full gene coverage & CNV analysis | 80–90% sensitivity; may miss deep intronic variants |
| Method | Next Generation Sequencing (NGS) + Sanger confirmation | Targeted mutation panel only |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
Physician Insight & Safety Protocols
“A negative result on this ATP2B3 test does not rule out other genetic or acquired ataxias; clinical correlation and a comprehensive neurological evaluation remain essential. Patients must not interpret the result as a standalone diagnosis—always consult a neurologist for interpretation. Our laboratory provides post‑test counseling to help you understand the implications for family members and potential carrier status.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory
Medication Advisory:
Do not discontinue, alter, or initiate any neurological medication without explicit guidance from your treating physician. Genetic test results should complement, not replace, clinical management decisions.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent (guardian required for minors), severe bleeding disorders, or acute infection at the draw site.
- Pregnancy: Discuss with your obstetrician and genetic specialist; genetic testing during pregnancy should be guided by a perinatologist.
- Emergency Red Flags: Sudden worsening of ataxia, severe headache, vision loss, or difficulty breathing—seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What does the ATP2B3 gene test diagnose?
It detects ATP2B3 mutations causing X‑linked spinocerebellar ataxia type 1, enabling precise diagnosis and genetic counseling. The test identifies pathogenic variants in the ATP2B3 gene responsible for this rare neurological disorder, confirms clinical suspicion, and helps differentiate it from other ataxias. The result guides carrier testing for female relatives and future family planning decisions.
2. How is the sample collected?
A certified phlebotomist collects peripheral whole blood (3–5 mL in EDTA tube) at your home or office via our VIP mobile phlebotomy service (daily 8 AM–11 PM). The sample is immediately placed in a validated temperature‑controlled cold‑chain transport system. Alternatively, previously extracted DNA or a single drop of blood on an FTA card may be accepted. All samples are handled under strict UAE PDPL data privacy protocols.
3. What is the turnaround time and cost?
Results are delivered within three to four weeks at a total cost of AED 2,800. The price covers NGS sequencing, bioinformatics analysis, clinical report, and a post‑test tele‑consultation with genetic counseling. Direct insurance billing can be verified via WhatsApp.
UAE Regulatory & Data Privacy Adherence
This test is performed under DHA Facility License No. 1143 at DNA Labs UAE. All procedures comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for health data protection. Our laboratory is ISO 9001:2015 certified (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | ATP2B3 Gene Spinocerebellar Ataxia Type 1 (X‑Linked) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube), extracted DNA, or FTA card; VIP mobile phlebotomy available daily 8 AM–11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger confirmation; full gene coverage & CNV analysis |
| ICD‑10‑CM Code | G11.8, Z14.8, Z82.79 |
| LOINC Code | 21643-9 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians